Biotin, also known as vitamin B7, can throw off a surprisingly wide range of lab tests, from thyroid panels and hormone levels to cardiac markers, cancer screenings, and even HIV and hepatitis serology. The interference happens because many modern immunoassays rely on a chemical pairing between biotin and a protein called streptavidin to detect target molecules in your blood. When you take supplemental biotin, excess biotin circulating in your bloodstream competes with the biotin built into the test, producing results that look real but are wrong. The list of affected tests is longer than most people realize, and the consequences have ranged from unnecessary cancer workups to children being put on anti-thyroid drugs they never needed.
How Biotin Disrupts Lab Results
The biotin-streptavidin bond is one of the strongest non-covalent bonds found in nature, and lab test manufacturers have exploited it for decades. In a typical immunoassay, biotin is attached to an antibody or antigen inside the test kit, and streptavidin anchors the whole reaction to a surface so the result can be measured. When your blood sample has extra biotin floating around from a supplement, that free biotin grabs onto the streptavidin before the test’s own biotin-labeled components can, disrupting the measurement.
The direction of the error depends on the test design. In competitive immunoassays, which are commonly used to measure small molecules like thyroid hormones, biotin interference falsely increases the reported value. In sandwich immunoassays, used for larger molecules like TSH or troponin, the interference falsely decreases the value.1PubMed. Immunoassay design and biotin interference This means a single supplement can push some results artificially high and others artificially low on the same lab report, creating a confusing clinical picture that mimics real disease.
Thyroid Tests Are the Most Commonly Affected
Thyroid function panels are among the most frequently disrupted tests because they rely heavily on biotin-streptavidin immunoassays. The classic pattern is a falsely low TSH combined with falsely high free T4 and free T3, which together look exactly like hyperthyroidism or Graves’ disease on paper. In one published case, a patient with multiple sclerosis taking high-dose biotin had thyroid results consistent with thyrotoxicosis despite having no symptoms whatsoever. The values returned to normal within a week of stopping biotin.2PubMed Central. Effect of High-dose Biotin on Thyroid Function Tests: Case Report and Literature Review
The problem isn’t limited to people on massive doses prescribed for neurological conditions. A 67-year-old woman taking just 5 mg of biotin daily, a dose found in many over-the-counter hair and nail supplements, showed up with low TSH, low parathyroid hormone, and mildly elevated calcium. Her doctors initially suspected a possible malignancy because of the calcium-PTH pattern, and the suppressed TSH pointed toward hyperthyroidism. After the biotin was discontinued, all values normalized within a month.3PubMed Central. Clinically Significant Lab Errors due to Vitamin B7 (Biotin) Supplementation: A Case Report Following a Recent FDA Warning Five milligrams is not an unusual dose; many “beauty” supplements contain that amount or more.
The thyroid panel is also where interference has caused the most documented harm in children. A seven-month-old with kidney failure was given 20 mg of biotin daily for metabolic acidosis and subsequently showed lab results pointing to hyperthyroidism, including high free T4 and free T3 with low TSH. The child was started on anti-thyroid medication. Only later was the discrepancy traced back to biotin interference, meaning the infant had been treated with a drug for a condition that existed only on the lab report.4PubMed Central. Pseudo-hyperthyroidism: Biotin interference in a case with renal failure
The Full List of Affected Tests Is Extensive
Thyroid panels get most of the attention, but volunteer studies have shown interference across a much broader set of lab tests. In studies where healthy people took a single dose of biotin ranging from 10 to 300 mg, interference was documented in free T4, free T3, thyroglobulin, DHEAS, estradiol, testosterone, ferritin, progesterone, vitamin B12, PSA, parathyroid hormone, luteinizing hormone, and follicle-stimulating hormone. A separate study found that even 10 mg daily for one week was enough to cause interference in 9 of 23 tested immunoassays across three major manufacturers, including TSH, total T3, free T4, free T3, PTH, NT-proBNP (a heart failure marker), and 25-hydroxyvitamin D.5The Journal of Applied Laboratory Medicine. AACC Guidance Document on Biotin Interference in Laboratory Tests
That list covers a startling range of clinical scenarios. A falsely elevated estradiol or testosterone could prompt unnecessary workups for hormone-producing tumors. A falsely low ferritin might lead to iron infusion therapy you don’t need. A falsely low vitamin D level could result in high-dose supplementation on top of adequate stores. And because different tests on the same panel may shift in opposite directions, the overall pattern can look like a real endocrine disorder rather than an artifact.
Cancer Screening and Tumor Markers
Prostate-specific antigen, or PSA, is one of the tests vulnerable to biotin interference, and the stakes are high. In one documented case, a 72-year-old man who had been previously treated for prostate cancer with surgery and radiation showed a PSA level of 5.86 µg/L, a result that would normally trigger concern for cancer recurrence and likely prompt imaging, biopsies, or both. The elevated reading turned out to be entirely due to biotin supplementation. Within four days of stopping biotin, his PSA dropped to less than 0.05 µg/L, effectively undetectable.6PubMed Central. Case – Biotin supplements interfering with prostate-specific antigen assays A cautionary tale Without catching the interference, the patient would have faced unnecessary procedures and significant anxiety over a cancer scare that was completely artifactual.
PSA is measured on many of the same biotin-streptavidin platforms used for thyroid and hormone tests. Because PSA is a competitive assay on some platforms, biotin can push the result falsely high, which is the worst possible direction of error for a cancer screening test. This makes biotin disclosure particularly important for anyone undergoing cancer surveillance.
Cardiac Troponin and Heart Failure Markers
High-sensitivity cardiac troponin T, the test used to diagnose heart attacks in emergency departments, uses biotin-streptavidin chemistry on some widely used platforms. Because troponin is measured with a sandwich immunoassay, biotin interference pushes the result falsely low. In a time-critical setting like a possible heart attack, a falsely low troponin could lead a clinical team to send someone home who is actively having a cardiac event. NT-proBNP, a marker used to evaluate heart failure, is similarly affected.5The Journal of Applied Laboratory Medicine. AACC Guidance Document on Biotin Interference in Laboratory Tests The emergency medicine context makes this interference especially dangerous because decisions are made fast and repeated testing may not happen before a patient is discharged.
The clinical trial of high-dose biotin (MD1003) for progressive multiple sclerosis confirmed this concern in a real-world treatment setting. Despite the use of mitigation strategies, the trial documented inaccurate laboratory results for tests using biotinylated antibodies.7The Lancet Neurology. Efficacy and safety of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled trial If interference could not be reliably prevented even in a controlled clinical trial where everyone knew patients were taking biotin, the risk in routine clinical care, where biotin use often goes unmentioned, is clearly real.
Infectious Disease Screening
Some of the most alarming interference data involves tests for HIV, hepatitis B, and hepatitis C. In one study examining serological markers at the theoretical peak biotin concentration following a 100 mg dose, half of anti-HIV results and two-thirds of anti-hepatitis C results came back falsely negative. For hepatitis B, biotin caused false-negative anti-HBs results (the marker showing immunity) in 40% of cases and false-positive anti-HBc and anti-HBe results in 90% and 80% of cases, respectively.8PubMed. Biotin interferences: Have we neglected the impact on serological markers?
A separate investigation using the VITROS analyzer system confirmed the problem for hepatitis markers, finding that at high biotin concentrations, nearly 88% of positive IgM anti-HBc samples came back falsely negative, and 100% of negative total anti-HAV samples came back falsely positive.9PubMed. Determination of potential biotin interference on accuracy of results of serologic assays for various viral hepatitis markers The practical implication is stark: a person with active hepatitis B could test negative and not receive treatment, while a person without hepatitis A could receive a false-positive result, triggering contact tracing and public health notification for a non-existent infection.
Point-of-care rapid HIV tests are also vulnerable. In lab testing, HIV-1 p24 antigen went undetected at concentrations of 30 pg/mL when biotin was present at 200 ng/mL, a level achievable with high-dose supplementation.10PubMed Central. Biotin Interference in Point of Care HIV Immunoassay Rapid tests used in clinics and community screening settings are designed for speed and accessibility, not for catching supplement interference, making this a meaningful gap in real-world screening.
Point-of-Care Pregnancy Tests
Urine pregnancy tests at the point of care are generally safer from biotin interference, but not universally. When researchers tested seven commercial point-of-care urine hCG devices using samples from volunteers taking 10 mg of biotin daily, six of the seven showed no evidence of interference. One device, however, showed a marked decrease in control line intensity at higher biotin concentrations, which could lead to an unreadable or ambiguous result.11PubMed. Assessment of biotin interference with qualitative point-of-care hCG test devices The takeaway is that most home and clinic pregnancy tests are likely unaffected at typical supplement doses, but the possibility is not zero, and device-to-device variation exists.
How Much Biotin Is Enough to Cause Problems
The adequate intake of biotin for adults is 30 micrograms per day. Most multivitamins contain 30 to 100 micrograms, which is unlikely to cause detectable interference. The trouble starts with the standalone “hair, skin, and nails” supplements that commonly contain 2,500 to 10,000 micrograms (2.5 to 10 mg). At the extreme end, neurological treatment doses for multiple sclerosis have ranged up to 300 mg daily.
Volunteer studies have demonstrated measurable interference from a single 10 mg dose, and some assays showed interference persisting for hours to days depending on the dose and the individual’s kidney function.5The Journal of Applied Laboratory Medicine. AACC Guidance Document on Biotin Interference in Laboratory Tests People with reduced kidney function clear biotin more slowly, which means the interference lasts longer and reaches higher blood levels at the same dose. The pediatric case described earlier involved a child with renal failure, and the seven-month-old’s kidney impairment almost certainly amplified the problem.
Even among people not taking therapeutic megadoses, survey data show that biotin supplement use is not rare. Roughly 7.7% of outpatients in one U.S. study reported taking biotin, and about 7.4% of emergency department patients had plasma biotin concentrations at or above the lowest known threshold for interference on Roche immunoassays.12PubMed. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department National survey data show that daily use of biotin at 1 mg or more increased nearly thirty-fold from 1999 to 2016, with particularly high use among women over 60.13JAMA. Trends in Daily Use of Biotin Supplements Among US Adults, 1999-2016 This is exactly the population most likely to be getting thyroid panels, cardiac markers, and cancer screenings drawn regularly.
Why Doctors Often Don’t Know You’re Taking It
One of the reasons biotin interference persists as a clinical problem is that patients frequently don’t mention it and clinicians frequently don’t ask. In one endocrine clinic survey, only 3.4% of patients had biotin listed in their medical record’s medication list, even though a much larger proportion reported taking it when specifically asked. Two-thirds of the patients who acknowledged biotin use could not state the exact dose they were taking.14Endocrine Practice. Assessment of Biotin Usage Prevalence in a Residency Clinic Population and Potential Implications for Laboratory Testing Many people think of biotin as a cosmetic supplement rather than a medication and don’t consider it worth mentioning, and electronic health record systems rarely flag over-the-counter supplements the way they flag prescription drugs.
Estimates of who is taking biotin vary partly because patients may not even realize their supplement contains it. Biotin appears in multivitamins, prenatal vitamins, B-complex formulas, and standalone beauty products, sometimes under the name vitamin B7 or vitamin H.15PubMed. Best practices in mitigating the risk of biotin interference with laboratory testing If you’re scheduled for blood work of any kind, checking the label of every supplement you take is worth the few minutes.
What You Should Do Before Lab Work
The simplest and most reliable way to avoid biotin interference is to stop taking it before your blood draw. Most guidance suggests stopping biotin supplementation at least 72 hours before lab work if you’re taking high doses. For standard over-the-counter doses of 5 to 10 mg, 24 to 48 hours is often sufficient for biotin levels to drop below interference thresholds, though this depends on kidney function. If you have chronic kidney disease, a longer washout period is safer because your body clears biotin more slowly.
Tell your doctor and the lab that you take biotin. This sounds obvious, but the clinic survey data show it almost never happens spontaneously. If you’ve already had lab results drawn while on biotin and the results seem clinically inconsistent, your doctor can repeat the tests after a washout period or send the sample to a lab using a different assay platform that doesn’t rely on biotin-streptavidin chemistry.
How Laboratories Are Addressing the Problem
Lab scientists have developed several strategies to deal with biotin interference. The most straightforward is a biotin depletion step performed before running the assay. One validated method uses the streptavidin-coated magnetic particles that are already a component of most affected assays to soak up free biotin from the sample before the test runs. This technique has been shown to restore normal results even in patients taking 300 mg of biotin daily for multiple sclerosis, and it works for both competitive and sandwich assay formats without altering sample volume, which is especially important for free thyroid hormone measurements.16PubMed. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays
More recent work has refined this approach. One group developed an optimized concentration of streptavidin-coated microparticles that could resist biotin levels up to 500 ng/mL while keeping a minimal impact on the optical signal.17PubMed Central. Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays Another study demonstrated a biotin depletion method that effectively restored accuracy for assays when biotin levels were below 400 ng/mL.18Practical Laboratory Medicine. Biotin interference in routine clinical immunoassays These are meaningful advances, but they require the lab to know interference is a possibility, which circles back to the communication gap between patients and providers.
Some newer-generation immunoassay platforms have been redesigned to reduce or eliminate biotin-streptavidin chemistry altogether. Mass spectrometry-based methods, which measure molecules by their physical properties rather than by antibody binding, are immune to biotin interference entirely. These methods are becoming more available for certain analytes like thyroid hormones and vitamin D, though they are not yet standard for every test in every lab.
Not Every Assay Platform Is Equally Vulnerable
The degree of interference depends heavily on which manufacturer’s assay system your lab uses. Roche immunoassay platforms have historically been the most studied and are among the most susceptible because they rely heavily on streptavidin-biotin technology. Siemens and Ortho Clinical Diagnostics platforms also showed interference in volunteer studies, though not for the same set of analytes.5The Journal of Applied Laboratory Medicine. AACC Guidance Document on Biotin Interference in Laboratory Tests Abbott platforms, which use a different capture chemistry, are generally considered less susceptible, though not entirely immune in all configurations. This variability means that the same blood sample could produce accurate results at one hospital and erroneous results across town, depending on equipment.
If you or your doctor suspect biotin interference, one practical option is to have the test repeated on a platform from a different manufacturer. When results from two different platforms agree, interference is much less likely. When they diverge, the platform-specific result that aligns with the clinical picture is generally the reliable one. Laboratories performing the biotin depletion step can also run the assay before and after depletion on the same platform; if the results change substantially, that confirms interference was present.
Biotin in Foods Versus Supplements
You cannot eat your way to biotin interference. The biotin present in foods like eggs, nuts, salmon, and sweet potatoes is bound to proteins and absorbed slowly. Even a diet unusually rich in biotin-containing foods results in blood levels well below the thresholds that cause assay problems. The interference arises specifically from supplemental biotin, which is free (unbound) and reaches the bloodstream in much higher concentrations, especially when taken in milligram-range doses. This distinction matters because some people worry about eating eggs or liver before lab work, and there is no reason to. The concern begins and ends with supplements and prescribed high-dose biotin therapy.